SEARCH

SEARCH BY CITATION

References

  • Bottoms, G.D., Roesel, O.F., Raush, F.D. and Akins, E.L. (1972) Orcadian variation in plasma Cortisol and corticosterone in pigs and mares. Am. J. vet. Res 33, 785790.
  • Bressot, C., Meunier, P.J., Chapuy, M.C., Lejeune, E., Edouard, C. and Darby, A.J. (1979) Histomorphometric profile, pathophysiology and reversibility of corticosteroid-induced osteoporosis. Metab. Bone Dis 1, 303309.
  • Delmas, P.D., Chatelain, P., Malaval, L. and Bonne, G. (1986) Serum bone gla protein in growth hormone deficient children. J. Bone Miner. Res 1, 333338.
  • Delmas, P.D. (1990) Biochemical markers of bone turnover for the clinical assessment of metabolic bone disease. Endocrinol. Metab. Clin. N. Am 19, 118.
  • Gallop, P.M., Lian, J.B. and Hauschka, P.V. (1980) Carboxylated calcium-binding proteins and vitamin K. N. Engl. J. Med 302, 14601466.
  • Garrel, D.R., Delmas, P.D., Welsh, C., Arnaud, M.J., Hamilton, S.E. and Pugeat, M. M. (1988) Effects of moderate physical training on prednisone-induced protein wasting: a study of whole-body and bone protein metabolism. Metabol 37, 257262.
  • Godschalk, M.F. and Downs, R.W. (1988) Effect of short-term glucocorticoids on serum osteocalcin in healthy young men. J. Bone Miner. Res 3, 113115.
  • Hauschka, P.V., Lian, J.B., Cole, D.E.C. and Gundberg, C.M. (1989) Osteocalcin and matrix Gla protein: Vitamin K-dependent proteins in bone. Physiol. Rev 69, 9901047.
  • Hodgson, S.F. (1990) Corticosteroid-induced osteoporosis. Endocrinol. Metab. Clin. N. Am 19, 95111.
  • Hope, E., Johnston, S.D., Hegstad, R.L., Geor, R.J. and Murphy, M.J. (1993) Effects of sample collection and handling on concentrations of osteocalcin in equine serum. Am. J. vet. Res 54, 10171020.
  • Johanssen, J.S., Giwercman, A., Hartwell, D., Nielsen, C.T., Price, P.A., Christiansen, C. and Skakkebaek, N.E. (1988) Serum bone gla-protein as a marker of bone growth in children and adolescents: Correlations with age, height, serum insulin-like growth factor I, and serum testosterone. J. Clin. Endocrinol. Metabol 67, 273278.
  • Lepage, O.M., Marcoux, M. and Tremblay, A. (1990) Serum osteocalcin or bone gla-protein, a biochemical marker for bone metabolism in horses: differences in serum levels with age. Can. J. vet. Res 54, 223226.
  • Lepage, O.M., DesCoteaux, L., Marcoux, M. and Tremblay, A. (1991) Circadian rhythms of osteocalcin in equine serum. Correlation with alkaline phosphatase, calcium, phosphate and total protein levels. Can. J. vet. Res 55, 510.
  • Lepage, O.M., Marcoux, M., Tremblay, A. and Dumas, G. (1993) Serum osteocalcin concentration in horses treated with triaminoclone acetonide. Am. J. vet. Res 54, 12091212.
  • Maenpaa, P.H., Pirskanen, M.S. and Koskinen, E. (1988) Biochemical indicators of bone formation in foals after transfer from pasture to stables for the winter months. Am. J. vet. Res 48, 19901992.
  • Morrison, N.A., Shine, J. and Fragonas, J-C. (1989) 1,25-Dihydroxyvitamin D-responsive element and glucocorticoid repression in the osteocalcin gene. Science 246, 11581161.
  • Ortoft, G. and Oxlund, H. (1988) Reduced strength of rat cortical bone after glucocorticoid treatment. Calcif. Tiss. Int 43, 376382.
  • Pastoureau, P., Vergnaud, P., Meunier, P.J. and Delmas, P.D. (1993) Osteopenia and bone-remodeling abnormalities in warfarin-treated lambs. J. Bone Miner. Res 8, 14171426.
  • Patterson-Buckendahl, P.E., Grindeland, R.E., Shakes, D.C., Morey-Holton, E.R. and Cann, C.E. (1988) Circulating osteocalcin in rats is inversely responsive to changes in corticosterone. Am. J. Physiol 254, R828R833.
  • Peretz, A., Praet, J.P. and Busson, D. (1989) Serum osteocalcin in the assessment of corticosteroid induced osteoporosis: effect of long and short term corticosteroid treatment. J. Rheumatol 16, 363367.
  • Robinson, N.E. (1992) Table of drugs: Approximate doses In: Current Therapy in Equine Medicine 3 W.B. Saunders Company, Philadelphia, USA. pp 815821.
  • Slovik, R.M., Gundberg, C.M., Neer, R.M. and Lian, J.B. (1984) Clinical evaluation of bone turnover by serum osteocalcin measurement. J. clin. Endocrinol. Metabol 59, 228230.
  • Stromstedt, P.E., Poellinger, L. and Gustafsson, J.A. (1991) The glucocorticoid receptor binds to a sequence overlapping the TATA box of the human osteocalcin promoter: a potential mechanism for negative regulation. Mol. Cell. Biol 11, 33793383.